Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) has scheduled its first quarter 2025 financial results conference call for May 7, 2025, at 5:00 pm eastern time. The company will provide investors and stakeholders access to the conference call through multiple channels:

• Live webcast access
• Telephone participation (requires advance registration)
• Replay availability on the company's Investors webpage

Registered telephone participants will receive confirmation emails with dial-in details, including a unique passcode and registrant ID for call access.

GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025.

Participants can access the conference call live via webcast, and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions 
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com  

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

FAQ

When will Emergent BioSolutions (EBS) release Q1 2025 earnings?

Emergent BioSolutions will release its Q1 2025 earnings on May 7, 2025, with a conference call scheduled for 5:00 pm eastern time.

How can investors join the Emergent BioSolutions Q1 2025 earnings call?

Investors can join via webcast through the Investors page of Emergent's website or by telephone after registering in advance to receive dial-in information.

Will there be a replay available for EBS Q1 2025 earnings call?

Yes, a replay of the earnings call will be available on the Investors page of Emergent BioSolutions' website.

What information is needed to access EBS Q1 2025 earnings call by phone?

Phone participants need to register in advance to receive a confirmation email containing the dial-in number, unique passcode, and registrant ID.